Related Experiment Video
Updated: Mar 26, 2026

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas
Published on: November 11, 2025
PKR is not obligatory for high-fat diet-induced obesity and its associated metabolic and inflammatory complications
G I Lancaster1, H L Kammoun1, M J Kraakman1
1Cellular and Molecular Metabolism Laboratory, BakerIDI Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia.
Abstract:
Protein kinase R (PKR) has previously been suggested to mediate many of the deleterious consequences of a high-fat diet (HFD). However, previous studies have observed substantial phenotypic variability when examining the metabolic consequences of PKR deletion. Accordingly, herein, we have re-examined the role of PKR in the development of obesity and its associated metabolic complications in vivo as well as its putative lipid-sensing role in vitro. Here we show that the deletion of PKR does not affect HFD-induced obesity, hepatic steatosis or glucose metabolism, and only modestly affects adipose tissue inflammation. Treatment with the saturated fatty acid palmitate in vitro induced comparable levels of inflammation in WT and PKR KO macrophages, demonstrating that PKR is not necessary for the sensing of pro-inflammatory lipids. These results challenge the proposed role for PKR in obesity, its associated metabolic complications and its role in lipid-induced inflammation.
Insights
Protein kinase R (PKR) does not significantly impact high-fat diet-induced obesity or related metabolic issues. This study found PKR is not essential for sensing pro-inflammatory lipids, challenging its proposed role in metabolic disease.
Area of Science:
- Biochemistry
- Metabolism
- Immunology
Background:
- Protein kinase R (PKR) has been implicated in mediating adverse effects of high-fat diets (HFD).
- Previous research shows considerable variability in metabolic outcomes following PKR deletion.
- The precise role of PKR in diet-induced metabolic dysfunction remains unclear.
Purpose of the Study:
- To re-evaluate the role of PKR in HFD-induced obesity and metabolic complications in vivo.
- To investigate the putative lipid-sensing role of PKR in vitro.
- To clarify PKR's involvement in inflammation triggered by saturated fatty acids.
Main Methods:
- Utilized PKR knockout (PKR KO) and wild-type (WT) mouse models fed a high-fat diet.
- Assessed obesity, hepatic steatosis, glucose metabolism, and adipose tissue inflammation.
- Examined inflammatory responses in WT and PKR KO macrophages treated with palmitate in vitro.
Main Results:
- PKR deletion did not alter HFD-induced obesity, hepatic steatosis, or glucose metabolism.
- Adipose tissue inflammation was only modestly affected by PKR deletion.
- Palmitate treatment induced similar inflammation levels in WT and PKR KO macrophages, indicating PKR is dispensable for lipid-sensing.
Conclusions:
- PKR does not play a critical role in the development of obesity or associated metabolic complications driven by HFD.
- PKR is not required for macrophages to sense and respond to pro-inflammatory saturated fatty acids.
- These findings challenge the established role of PKR in metabolic disease pathogenesis and lipid-induced inflammation.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Obesity
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
cAMP-dependent Protein Kinase Pathways

